The shares of the prominent specialty chemicals gained up to 2 percent in today’s trading session after SBI Mutual Fund acquired 2,10,000 equity shares via a Block deal.
With a market capitalization of Rs 21,375.08 crore, the shares of Navin Fluorine International Ltd were trading at Rs 4,310.35 per share, increasing around 0.80 percent as compared to the previous closing price of Rs 4,276.05 apiece.
Nse Deal
According to NSE, SBI Mutual Fund acquired 2.1 lakh equity shares at an average price of Rs 4,287 per share via a Block Deal; however, a promoter of the firm, Vishad Padmanabh Mafatlal, offloaded the same number of equity shares, which is valued at Rs 90 crores.
Q4 & Operational Highlights
Recently, the company reported positive Q4 results, revenue increased by 15 percent on a quarter-on-quarter basis from Rs 606 crore in Q3FY25 to Rs 701 crore in Q4FY25. Further, revenue increased by 16 percent year on year, from Rs 602 crore in Q4FY24 to Rs 701 crore in Q4FY25. The company’s net profit increased by 13 percent on a quarter-on-quarter basis, from Rs. 84 crore in Q3FY25 to Rs. 95 crore in Q4FY25. Further, net profit magnified significantly by 36 percent year on year from Rs 70 crore in Q4FY24 to Rs 95 crore in Q4FY25.
The company’s specialty chemicals segment saw a marginal 1 percent revenue growth in Q4FY25 to Rs 259 crore, with 68 percent international share. The company achieved optimal capacity utilization at Dahej and Surat, began fluoro specialty production, invested Rs 30 crore in Surat, and plans to launch two new molecules in FY26.
Additionally, the CDMO vertical posted a 141 percent YoY revenue jump in Q4FY25 to Rs 115 crore, with 77 percent international contribution. Growth was driven by a strong pipeline of RFQs and orders. cGMP4 capex of Rs 288 crore is underway, with Rs 160 crore Phase 1 commissioning by Q3FY26.
Navin Fluorine International Limited is an India-based company that is primarily focused on fluorine chemistry, which produces refrigeration gases, inorganic fluorides, and specialty organofluorines. The Company operates through the Chemical Business segment.
Written by Abhishek Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
